← Back to Patent Explorer
US4399125A Expired / Lapsed US ⏱️ 0.0 years remaining

Novel antagonists of the antidiuretic action of arginine vasopressin

Assignee: Individual
•
Filing: 1981-11-16
•
Granted: 1983-08-16
•
Expires: 2001-11-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds acting as antagonists of the antidiuretic activity of arginine vasopressin are those of the formula <IMAGE> wherein X is D-Phe, D-Val, D-Leu, D-Ile, D-Arg, D-norvaline, D-norleucine, D-cyclohexylalanine, D- alpha -aminobutyric acid, D-threonine or D-methionine and Z is D- or L-Arg.

Inventors

  • 👤 Maurice Manning
  • 👤 Wilbur H. Sawyer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 12:49
CPC Classifications
C; C07; C07K; C07K7/00; C07K7/04; C07K7/16; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/15

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 28 words
A compound of the formula ##STR4## wherein X is D-Phe, D-Val, D-Leu, D-Ile, D-Arg, D-norvaline, D-norleucine, D-cyclohexylalanine, D-α-aminobutyric acid, D-threonine or D-methionine and Z is D- or L-Arg.
Claim 2
Dependent Claim 28 words
A compound of the formula ##STR4## wherein X is D-Phe, D-Val, D-Leu, D-Ile, D-Arg, D-norvaline, D-norleucine, D-cyclohexylalanine, D-α-aminobutyric acid, D-threonine or D-methionine and Z is D- or L-Arg.
Claim 3
Dependent Claim 13 words
A compound of claim 1, wherein X is D-Phe, D-Val, D-Leu or D-Ile.
Claim 4
Dependent Claim 9 words
A compound of claim 1, wherein Z is L-Arg.
Claim 5
Dependent Claim 10 words
[1-(β-Mercapto-β,β-cyclopentamethylenepropionic acid), 2-D-phenylalanine, 4-valine]-arginine vasopressin, a compound of claim 1.
Claim 6
Dependent Claim 10 words
[1-(β-Mercapto-β,β-cyclopentamethylenepropionic acid), 2-D-valine, 4-valine]-arginine vasopressin, a compound of claim 1.
Claim 7
Dependent Claim 10 words
[1-(β-Mercapto-β,β-cyclopentamethylenepropionic acid), 2-D-leucine, 4-valine]-arginine vasopressin, a compound of claim 1.
Claim 8
Dependent Claim 10 words
[1-(β-Mercapto-β,β-cyclopentamethylenepropionic acid), 2-D-isoleucine, 4-valine]-arginine vasopressin, a compound of claim 1.
Claim 9
Dependent Claim 11 words
[1-(β-Mercapto-β,β-cyclopentamethylenepropionic acid), 2-D-phenylalanine, 4-valine, 8-D-arginine] vasopressin, a compound of claim 1.
Claim 10
Dependent Claim 53 words
A method for antagonizing the in vivo response of an animal to the antidiuretic action of an antidiuretic hormone, comprising administering to the animal being treated an amount of a compound of claim 1, in admixture with a physiologically and pharmaceutically acceptable carrier, effective to antagonize the antidiuretic response to the antidiuretic hormone.
Claim 11
Dependent Claim 12 words
The method of claim 9, wherein the antiduretic hormone is arginine vasopressin.
Claim 12
Dependent Claim 11 words
The method of claim 9, wherein the compound is administered parenterally.
Claim 13
Dependent Claim 53 words
A method for antagonizing the in vivo response of an animal to the antidiuretic action of an antidiuretic hormone, comprising administering to the animal being treated an amount of the compound of claim 7, in admixture with a physiologically and pharmaceutically acceptable carrier, effective to antagonize the antidiuretic response to the antidiuretic hormone.
Claim 14
Dependent Claim 53 words
A method for antagonizing the in vivo response of an animal to the antidiuretic action of an antidiuretic hormone, comprising administering to the animal being treated an amount of the compound of claim 4, in admixture with a physiologically and pharmaceutically acceptable carrier, effective to antagonize the antidiuretic response to the antidiuretic hormone.

References Cited (Backward Citations)

US3415805A Cited
US3371080A Cited
US3454549A Cited
US3418307A Cited
US3497491A Cited
US4148787A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-08-15 1987-02-14 1987-08-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-08-15 1991-02-14 1991-08-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-08-15 1995-02-14 1995-08-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag